|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3,3'-Dichlorobenzidine (and its salts) |
CAS 91-94-1 | ||
NH2ClC6H3C6H3ClNH2 |
RTECS DD0525000 | ||
|
Synonyms & Trade Names 4,4'-Diamino-3,3'-dichlorobiphenyl; Dichlorobenzidine base; o,o'-Dichlorobenzidine; 3,3'-Dichlorobiphenyl-4,4'-diamine; 3,3'-Dichloro-4,4'-biphenyldiamine; 3,3'-Dichloro-4,4'-diaminobiphenyl |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: Ca See Appendix A | ||
| OSHA PEL: [1910.1007] See Appendix B | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion | ||
|
Physical Description Gray to purple, crystalline solid. |
|||
|
MW: 253.1 |
BP: 788°F |
MLT: 271°F |
Sol(59°F): 0.07% |
|
VP: ? |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods NIOSH 5509; OSHA 65 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations (See Appendix E) NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Skin sensitization, dermatitis; headache, dizziness; caustic burns; frequent urination, dysuria; hematuria (blood in the urine); gastrointestinal upset; upper respiratory infection; [potential occupational carcinogen] | |
|
Target Organs
Bladder, liver, lung, skin, gastrointestinal tract Cancer Site [in animals: liver & bladder cancer] |
|
| See also: INTRODUCTION See ICSC CARD: 0481 See MEDICAL TESTS: 0074 |